MarshallDouglasBrinkleyMD

Cardiology • Nashville, TN

Heart Failure & Transplantation

Assistant Professor of Medicine

Join to view full profile

Dr. Brinkley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brinkley's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-2318

Fax+1 615-343-4841

Summary

Dr. Marshall Brinkley is a cardiologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center.

Education & Training

Brigham and Women's HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2015 - 2016
Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 2012 - 2015
Harvard School of Public HealthCertificate, Program in Clinical Effectiveness, 2014
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2007 - 2010
Vanderbilt University School of MedicineClass of 2007
Duke UniversityB.S., Biology & Chemistry, 1998 - 2002

Certifications & Licensure

TN State Medical License 2016 - 2026
AL State Medical License 2020 - 2020
MA State Medical License 2013 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Chief Fellow Beth Israel Deaconess Medical Center, 2014
Clinical Scientist Training Washington University, 2009
Magna cum laude Duke University, 2002
Distinction in Biology Duke University, 2002
Phi Beta Kappa Duke University, 2002
Join now to see all

Clinical Trials

A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) Start of enrollment: 2016 Sep 20
Completed
Phase 3
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction Start of enrollment: 2017 Jan 06
Completed
Phase 3
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035) Start of enrollment: 2021 Nov 02
Active, not recruiting
Phase 3
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM (SEQUOIA-HCM) Start of enrollment: 2022 Feb 01
Completed
Phase 3
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM Start of enrollment: 2023 Aug 30
Recruiting
Phase 3
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM Start of enrollment: 2023 Jun 19
Recruiting
Phase 3
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM Start of enrollment: 2021 May 06
Enrolling by invitation
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa, Theodore P Abraham, Douglas Marshall Brinkley
European Heart Journal. 2024-11-08
Denial for Advanced Heart Failure Therapies Due to Psychosocial Stressors: Who Comes Back?
Kayla Buttafuoco, Daniel Daunis, Tandra Carter, Jolaunda Hoye, Maura Webb
Journal of Cardiac Failure. 2024-09-24
1 citations
Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
Kaushik Amancherla, Irene D Feurer, Scott A Rega, Andrew Cluckey, Mohamed Salih
Journal of Cardiac Failure. 2024-05-01

Authored Content

Heart Failure Self-Assessment Program: Rejection (chapter)June 2020

Press Mentions

Using Pulmonary Artery Pressure Monitoring to Manage Obese HF Patients Leads to Strong OutcomesNovember 3rd, 2021

Committees

Education Committee, Heart Failure Society of America 2017 - 2019

Professional Memberships

American College of Cardiology - ACC
Member
Heart Failure Society of America
Member
International Society for Heart and Lung Transplantation
Member
American Heart Association - AHA
Member